Formpipe Preliminary Q4: High Costs Hurting Margins

Research Note

2025-01-20

08:58

Redeye comments on the preliminary Q4 figures from Formpipe. While hurting Q4 2024, the implications for 2025 and onwards are likely minor. However, the important ACV/ARR figures are not yet disclosed.

Fredrik Nilsson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.